CompaniesCIMYM BioSciences

CIMYM BioSciences

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

0

As Collaborator

3

Total Enrollment

91

By Phase

PHASE2: 1PHASE1/PHASE2: 1PHASE1: 1

By Status

TERMINATED: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00369252
Hover over trial bars to see details

Recent Trials

NCT00872482Collaborator
A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases
PHASE2Terminated
21 participants
Started: Apr 30, 2009 · Completed: Jul 31, 2011
NCT00369447Collaborator
A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer
PHASE1/PHASE2Terminated
52 participants
Started: Mar 31, 2009 · Completed: Jul 31, 2011
NCT00369252Collaborator
Phase I Study of Nimotuzumab in Solid Tumours
PHASE1Completed
18 participants
Started: Jun 30, 2005